Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis
<p><strong>Background</strong></p> The World Health Organization recommends protease inhibitor (PI)-based antiretroviral therapy (ART) as second-line and third-line regimens in pregnant women living with HIV (WLHIV). US, European, and UK guidelines include PI-based ART as fir...
Main Authors: | Cowdell, I, Beck, K, Portwood, C, Sexton, H, Kumarendran, M, Brandon, Z, Kirtley, S, Hemelaar, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis
by: Imogen Cowdell, et al.
Published: (2022-04-01) -
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis
by: Beck, K, et al.
Published: (2024) -
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis
by: Katharina Beck, et al.
Published: (2024-02-01) -
Association of nucleoside reverse transcriptase inhibitors with adverse perinatal outcomes in pregnant women living with HIV: systematic review and meta-analysis
by: Cowdell, I, et al.
Published: (2025) -
Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: a systematic review and meta-analysis
by: Portwood, C, et al.
Published: (2023)